27 participants
NeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV Melanoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-10-26
- Start Date:
- 2024-11-01
- Completion:
- 2026-05-31
Conditions
- Melanoma Stage IIIB-IV
Interventions
- DRUG
No Results Yet